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ABSTRACT 
INFLUENCE OF PREVIOUS CESAREAN SECTION ON CLINICAL OUTCOME OF 
MEDICATION ABORTION 
 
A retrospective chart review was conducted to assess for a relationship between previous 
Cesarean section delivery and failure of subsequent medication abortion. Several studies have 
shown a positive relationship between parity and failure of subsequent medication abortion; 
however, these studies did not isolate method of delivery (Cotte, Monniez, and Norel 2008; 
Ashok, Templeton, Wagaarachchi, & Flett, 2002; Niinimäki, Martikainen, and Talvensaari-
Mattila, 2004; Bartley, Tong, Everington, & Baird, 2000). The sample was 196 women who 
underwent medication abortion and returned for a two week follow-up appointment at an urban 
women’s health clinic during 2005-2010. The protocol for medication abortion was 200mg 
Mifepristone orally followed by 400mcg of misoprostol vaginally or buccally administered 12-
24 hours later. Failure was defined as positive pregnancy test at follow-up. Demographic and 
outcome data was collected from patient self-report pre-procedure intake and follow-up 
questionnaire forms. Parity regardless of delivery type increased the risk of failure (p=0.0422) 
but previous Cesarean section did not (p = 0.6141). Duration of cramps experienced after 
Misoprostol insertion were negatively correlated with age (r = -0.25448). A positive correlation 
was found between longer cramp duration and smoking status. A larger prospective study with a 
standardized formal clinician-guided measure is recommended. Future studies may benefit from 
a focus on other outcome measures—such as onset and duration of cramping or bleeding—rather 
than simply procedure failure or success. 
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I. Background 
Clinical Problem 
The usage of mifepristone and misoprostol to terminate pregnancy is becoming an 
increasingly popular choice for first-trimester abortion for women in the United States. In the 
period between 2005 and 2008, the number of these procedures—known as “medication 
abortions”—rose 24%, while the total abortion rate only increased 1% (Jones & Kooistra, 2011). 
Concurrently, the rate of Cesarean delivery in the United States has risen 56% since 1996 to 
32.3% of all 2008 births (Martin, Hamilton, et al. 2010). Several studies have shown a positive 
relationship between the number of previous full-term births and failure of subsequent 
medication abortion; however, these studies have not isolated method of delivery as a variable 
that may contribute to procedure failure (Cotte, Monniez, and Norel 2008; Ashok, Templeton, 
Wagaarachchi, & Flett, 2002; Niinimäki, Martikainen, and Talvensaari-Mattila, 2004; Bartley, 
Tong, Everington, & Baird, 2000). The combination of increasing use of medication abortion for 
termination and increasing rates of Cesarean section for delivery bring into focus a group of 
women who have had one or more previous Cesarean births who may choose medication 
abortion to terminate a pregnancy. 
This study explored the relationship between the phenomena of medication abortion 
outcome in the context of women with prior deliveries by Cesarean section. It was performed in 
the interest of helping advanced practice nurses, midwives and other clinicians provide more 
purposive anticipatory guidance to their patients who have had a previous Cesarean delivery on 
the option of medication abortion for first-trimester termination. Additionally, as advanced 
practice nurses move into the role of primary providers of medication abortion, it is hoped that 
the findings will forward clinical-decision making for these advance practice nurse abortion 
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providers regarding which patients are the best candidates for a pregnancy termination by 
medication abortion.  
Operational Definitions 
Abortion 
“The…induced termination of pregnancy before the fetus reaches a viable age.” (Taber’s 
Cyclopedic Medical Dictionary, 2009) 
Cesarean Section 
“The operation used to deliver a baby through its mother's abdominal wall. It is 
performed when the risks to mother or child of vaginal delivery are thought to outweigh the 
problems associated with operative delivery…The operation is usually performed through a low, 
horizontal ‘bikini line’ incision.” (Black’s Medical Dictionary, 2010, p. 716)  
Coping Score 
  A numerical value from 1-10 given by the patient as a response to the question, “On a 
scale of 1 to 10 (1 being the worst and 10 being the best) how well are you coping with your 
abortion?” on their follow-up visit questionnaire.  
Delivery Type 
Method of delivery of a newborn at the end of a full-term pregnancy: for this study, 
method is dichotomized to either vaginal delivery or Cesarean section. 
Medication Abortion 
Abortion is “the…induced termination of pregnancy before the fetus reaches a viable 
age.” (Taber’s Cyclopedic Medical Dictionary, 2009) Medication abortion is termination by 
usage of pharmacologic methods (Spitz, Bardin, Benton, & Robbins, 1998). 
Medication Abortion Failure 
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 Medication abortion failure is defined as a positive pregnancy test finding at a routine 
two week follow-up visit.  
Parity 
Number of previous live births. 
Smoking Status 
 A nominal value of yes or no to given by the patient in response to the question, 
“Smoker?” on the initial, pre-procedure intake questionnaire. It determines whether the patient 
currently is smoking a substance, with tobacco smoking implied.  
Review of the Literature 
Abortion is “the…induced termination of pregnancy before the fetus reaches a viable 
age” (Taber’s Cyclopedic Medical Dictionary, 2009). Medication abortion is induced 
termination by pharmacological, instead of surgical, means. It is performed by administering 
200mg of Mifepristone by mouth followed by a prostaglandin analogue, usually misoprostol, 
buccally or vaginally at a later time (Spitz, Bardin, Benton, & Robbins, 1998). The protocol for 
medication abortion used in the present study was 200mg of Mifepristone, a progesterone 
blocker, orally administered in the clinic setting followed by misoprostol, a prostaglandin 
analogue, administered vaginally or buccally by the patient in a 400mcg dose 12-24 hours after 
at home. This procedure is administered up to a gestational age of 63 days. Although reported 
success rates differ by the exact dosing of mifepristone and misoprostol and the interval between 
them, the success rate with this particular protocol was 97.5% in one large study (Kopp Kallner, 
Fiala, Stephansson, & Gemzell-Danielsson, 2010).  
Clinical studies on predictive factors of successful outcome with medication abortion 
have mainly focused on gestational age (Gomez, et al. 2010). Multiple studies of medication 
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abortion outcome have a positive association between increasing parity and probability of 
medication abortion failure (Cotte, Monniez, & Norel, 2008; Hedley, Turner, & Coyaji, et al., 
2004; Ashok, Templeton, Wagaarachchi, & Flett, 2002; Niinimäki, Martikainen, & Talvensaari-
Mattila, 2004; Bartley, Tong, Everington, & Baird, 2000). In Niinimaki et al. (2004) multiparous 
women had a higher rate of failure as defined by necessity for aspiration. The failure rate for 
nulliparas was 6%, increasing to 7.3% with 1-2 live births and 27.5% with three or more. 
Conversely, a patient with three or more pregnancies regardless of pregnancy outcome had a 
failure rate of 14.4%, whereas a patient with two pregnancies or less had a failure rate of only 
5.7%. LeFebvre et al. (2008) found that multiparas with four or more pregnancies had an 8% 
failure risk, almost 6 times the rate for nulliparas (1.4%), which persisted even after controlling 
for age.  
Influence of Previous Cesareans 
All studies previously discussed did not differentiate between Cesarean and vaginal 
delivery in participants with prior full term births. Two studies, both small retrospective chart 
studies, identify this interaction: Odeh, Tendler, Sosnovsky, et al. (2010) and Wang, Li, Manconi 
et al. (2010). Odeh, Tenderl, Sosnovsky, et al. (2010) completed a retrospective chart analysis 
study that included data on gravidity as well as parity. The sample included 403 women who had 
undergone medication abortion at a department of obstetrics and gynecology over the course of 
two years, subdivided into those who were primigravidas and those with one or more previous 
pregnancies. Those who had prior pregnancies were separated by those with previous 
terminations and those with previous Cesarean sections. Failure was defined as the requirement 
of uterine curettage. The rate of failure in the primiparous group was 8.2% versus 18.9% in all 
multiparous women. Subset analysis on the multiparas who had no history of abortion showed a 
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22.4% medication abortion failure rate, supporting the connection between previous term birth 
and medication abortion failure. Women who had only previous term births and no Cesarean 
section or abortion had a 19.2% failure rate; those who had only had one previous Cesarean 
section had a 40% failure rate. However, the subgroups of women who had had Cesarean 
sections, term births, or abortions were not clearly defined in quantity for the individual woman 
and therefore a more direct comparison could not be analyzed from the data presented.  
Wang, Li, Manconi, Dong, Zhang, & Sun (2010) also directly evaluated a connection 
between previous Cesarean delivery and subsequent medication abortion outcome. Charts were 
reviewed retrospectively from a larger sample of 668 women with previous uterine incision 
(Cesarean section or other procedure) without collecting other information on obstetrical history. 
The study established values for the variables at which curettage would be indicated in this 
population: "vaginal bleeding intervals ≥21 days and/or had a bilayer endometrial thickness ≥15 
mm and/or serum β-hCG ≥500 IU/L after a [medication] abortion" (Wang et al., 2010, p. 65). 
Wang et al.’s sample was comprised entirely of women with previous uterine incision. There was 
no control group of women without previous uterine incision to provide a comparison failure 
rate. Therefore it cannot be determined from the results whether the presence or absence of a 
previous uterine incision would affect outcome of medication abortion.  
In summary, research into the predictors of a successful medication abortion is limited, 
and the interaction between Cesarean delivery and outcome of subsequent medication abortion is 
no exception. Of the general studies that have been conducted, very few explore the relationship 
between parity and outcome; only two have directly studied Cesarean section specifically as a 
possible predictive risk factor in failure. Several studies have indicated that higher gravity or 
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parity was associated with an increased rate of incomplete abortion; however, there was no 
differentiation between methods of delivery. 
II. Research Methods 
Research Question 
Does a previous Cesarean delivery increase the risk of medication abortion procedure failure? 
Research Design 
This retrospective, de-identified triangulated or mixed methods chart review included 
quantitative research methods. The review was completed of patients who underwent medication 
abortion at a free-standing women’s health clinic located in an urban area in the northeastern 
United States who met two basic inclusion criteria. First, they underwent medication abortion at 
the center during the years 2005-2010; second, they returned for a routine two week follow-up 
visit and filled out a patient questionnaire at that time. Demographic information, specifically 
age, pertinent past medical history, and obstetric history, was collected from the pre-procedure 
intake form. Obstetric history included gravity, parity, and outcomes of previous pregnancies: 
previous spontaneous or therapeutic abortion, and vaginal delivery or Cesarean section.  
Data was also collected from written questionnaires completed by patients at the follow-
up visit after the procedure. These questionnaires elicit self-reported written qualitative data from 
the patients about their experiences of first-trimester medication abortion, as well as more 
quantitative scaled data on physiological aspects of the experience such as pain. The study 
specifically examined the interval between misoprostol administration and the onset of bleeding, 
duration of bleeding, onset and duration of cramping, and a scaled coping score.  
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Sample & Setting 
The convenience sample included 196 women who underwent medication abortion at a 
single free-standing family planning clinic in a socioeconomically disadvantaged, urban area in 
the Northeast United States in the years 2005-2010 and then returned for their follow-up 
appointment scheduled for two weeks after procedure. These patients were identified by hand-
reviewing their charts for inclusion elements of having completed both a medication abortion 
and follow-up appointment. 
Data Collection Instruments 
The data collection tool was an adaptation of the intake and follow-up visit forms at use 
in the clinic (Appendix A). As the instrument was simply an adaptation of these forms to 
facilitate entry into Statistical Analysis Software (SAS) Analytics, validity was assessed by 
standardizing the data into discrete categories after data collection as well as in anticipation of 
possible errors that could be corrected or accounted for before analysis was begun. 
Data Collection Procedures 
 All data was collected from paper-based medical charts on-site during the fall of 2011 
and recorded directly into the data collection tool on a secured laptop. The data collection tool 
was a front-end of the SAS database that was used for data analysis. 
Human subjects were protected by several means. First, no identifying information was 
recorded from the paper charts. In the study clinic, each individual patient encounter is contained 
in a single folder together with all of the patients’ previous visits. Therefore, no correlational list 
linking study numbers with identifiable patient information was needed to prevent subject 
redundancy and none was maintained. The patient’s age at time of procedure was recorded but 
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not the date of birth. As there was a sole investigator, no health information collected in this 
study was disclosed to others.  
Data Analysis 
SAS (version 9.2) and Statistical Package for Social Sciences (SPSS) (version 19) 
statistical software were used for the analyses. Fisher’s exact test was performed to determine if 
there was a significant association between positive pregnancy test result and previous Cesarean 
section. Fisher’s exact was used due to a small sample size. Pearson’s correlation coefficient was 
used to measure any correlation between continuous variables including bleeding onset and 
duration, cramping onset and duration, and coping score versus age, obstetrical history, Cesarean 
section, and whether the woman was currently smoking at the time of her abortion (smoker 
status).  
Linear regression was performed in SAS to predict a variety of outcomes including onset 
of bleeding, duration of bleeding, onset of cramping, duration of cramping, and coping score 
associated with abortion. Predictor variables included age, number of abortions, smoker status, 
and Cesarean section. Diagnostics were performed to assess normality through the normal 
probability plot. A log transformation was conducted on the outcome variable, cramp duration. 
Forward model selection was used to find the best fit model in SAS.  
 
III. Results 
Demographic data revealed that 30% of the women were age 21-26 years at the time of 
their medication abortion (Table 1). The procedure failure rate, defined as positive pregnancy 
test, was 4% in this study sample. The patients were all scheduled for a routine two week follow-
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up visit and returned for this an average of 18.4 days post misoprostol, with a range of 4 to 62 
days.  
Table 1  
Demographics of Patient Age in Years at Time of Procedure  
Group 15-20 21-26 27-32 33-37 38-44 
Total 
Number 42 59 40 37 18 196 
Percentage of 
Total 21% 30% 20% 18% 9% 99% 
Note: Due to rounding, percentages do not add up to 100%. 
 
Fisher’s Exact Test found a p value of 0.6141, showing that previous Cesarean section 
did not increase the likelihood of a positive pregnancy test on follow-up. Of the eight patients 
who had a positive pregnancy test at follow-up, six had never had a Cesarean section, one had 
one previous Cesarean section, and one had two previous Cesareans (Table 2). Parity on its own, 
regardless of delivery type, was found to be a risk factor for failure (p=0.0422) (Table 3). 
Table 2 
Patient Information by Previous Cesarean Section and Pregnancy Test Outcome at Follow-Up 
   
Previous Cesarean Section 
Outcome 0 1 2 3 Total 
Negative 150 23 11 2 186 
Positive 6 1 1 0 8 
Total 156 24 12 2 194 
Note: Due to data error, 2 cases are not included from the negative pregnancy test group.  
  
Influence of Cesarean Section on Medication Abortion  10 
 
Table 3 
Demographic Data on Parity and Pregnancy Test Outcome at Follow-Up 
     Number of Previous Pregnancies 
Outcome 0 1 2 3 4 7 Total 
Negative     
  
 
Frequency 121 41 15 5 5 1 188 
Percent 61.73 20.92 7.65 2.55 2.55 0.51 95.92% 
Positive        
Frequency 4 0 3 1 0 0 8 
Percent 2.04 0.00 1.53 0.51 0 0 4.08% 
Total 125 41 18 6 5 1 196 
 63.78 20.92 9.18 3.06 2.55 0.51 100% 
 
Coping score was not found to be correlated with previous Cesarean section, number of 
previous abortions, age or tobacco use. These demographic factors (previous Cesarean section, 
number of previous abortions, age, or tobacco use) were also not correlated with onset or 
duration of bleeding or onset of cramping after misoprostol. However, a Pearson correlational 
plot showed that the duration of cramps experienced after Misoprostol insertion were negatively 
correlated (y = -0.25448) with age. Additionally, a forward selection model showed a positive 
correlation between longer cramp duration and current smoker status (Table 4). 
Table 4 
Association Between Cramp Duration, Age, and Smoker Status 
  Variable  
Statistical Findings Intercept Age at Abortion Currently Smoking 
Parameter Estimate 79.60510 -1.72864 30.57794 
Standard Error 14.79580 0.52198 9.52439 
T Value 5.38 -3.31 3.21 
Pr > |t| <.001 0.0011 0.0016 
 
  
Influence of Cesarean Section on Medication Abortion  11 
 
IV. Discussion 
The purpose of this study was to see if there was a relationship between previous 
Cesarean section and the frequency of medication abortion failure. For those advance practice 
nurses who are primary providers of medication abortion, it is hoped that identification of the 
relationship between medication abortion success and prior history of Cesarean section will 
inform clinical decision-making when evaluating medication abortion as a possible option for a 
patient. The failure rate, as defined by a positive pregnancy test at follow-up, was 4% for all 
medication abortions, which is similar to previously published rates for the method (Kopp 
Kallner, Fiala, Stephansson, & Gemzell-Danielsson 2004). No significant relationship between 
Caesarean section and medication abortion failure was found with this study. Absolute number 
of previous pregnancies was found to be correlated with failure, which further confirms the 
positive correlation between parity and failure found by many previous studies (Cotte, Monniez, 
& Norel 2008; Hedley, Turner, & Coyaji et al., 2004; Ashok, Templeton, Wagaarachchi, & Flett, 
2002; Niinimäki, Martikainen, & Talvensaari-Mattila, 2004; Bartley, Tong, Everington, & Baird, 
2000).  
Similarly to the lack of relationship found between prior Cesarean section and failure, 
many secondary variables—obstetrical history variables of parity and previous abortion, use of 
tobacco, and age—were not found to be correlated with failure. They were also not correlated 
with this study’s measured aspects of the lived experience of a patient undergoing medication 
abortion. This includes  post-abortion coping, as well as onset and duration of bleeding and 
cramping after misoprostol administration.  
Incidental examination of other variables found two secondary dependent variables with 
significant connections to certain outcomes. Patient age was found to be negatively correlated 
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with length of cramp duration after misoprostol, although there was no controlling for 
differences in parity, which tends to increase with age. Although there is no evidence in the 
literature on relationships between age and cramp duration, this finding may add complexity to 
previous studies that show age as a negative factor in success rates (Hedley et al., 2004). Second, 
smoking status (current tobacco use) was found to be positively correlated with longer duration 
of cramping after misoprostol. This is a novel finding that has not been previously studied, and 
further inquiry into this connection, including factoring in quantity of cigarettes smoked and 
years of smoking history, may prove to be significant.  
Limitations of the Study 
This study has several important limitations. The self-reported nature of patient 
questionnaires contributes negatively to the dependability of the study. Beyond the universal 
issue of recall bias, there was little standardization in the answers provided by the patients. The 
validity and reliability of the tool, despite being exactly the same as the original forms, still rely 
on the quality of the data entered into the form. Although no charts were discarded in order to 
preserve the randomness of the sample, many had data that had to be interpreted by the author 
post-hoc. Retrospective, chart-only data collection with no direct patient contact also puts limits 
on the thoroughness of the data and limits the data by not allowing for a control group. 
Additionally, the sample was patients from a single clinical site with a homogenous 
patient demographic. Although sample size (n = 196) was determined to be sufficient to find no 
relationship between the primary variables, few overall failures may have limited the ability to 
find a statistically significant result. Therefore, these results are given in hopes of inspiring future 
research and are not generalizable. 
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Conclusion & Recommendations 
The objective of this study was to identify whether previous Cesarean section is a 
predictive measure of increased risk of medication abortion failure. The many limitations of the 
present study guide recommendations for future research. First, a prospective study with a more 
formal clinician-guided measure instead of patient self-report is recommended. A larger sample 
size, or a design that focused on chart review of only medication abortion failures, may bring 
more fruitful data on the topic of Cesarean section. Future studies may benefit from a focus on 
other outcome measures—such as onset and duration of cramping or bleeding—rather than 
simply clinical failure or success. A focus on the events that all women undergoing medication 
abortion might experience may have more utility in light of the infrequence of medication 
abortion failure. Repeating these findings in a larger, more standardized study with a control 
group could lead to a clinician being able to provide better pre-abortion reassurance that these 
factors are not shown to have a negative impact.   
If these preliminary and limited results are built upon by further studies, the lack of a 
connection between prior Cesarean section and increased frequency of medication abortion 
failure may lead providers to be able to more confidently recommend medication abortion as an 
option to women with previous Cesarean section deliveries. It is the hope that future inquiry will 
improve the anticipatory guidance given by advance practice nurses to their patients and the 
quality of reproductive healthcare in turn. 
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